查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球數位藥房市場：按藥物類型、產品類型、平台、商業模式 - 區域展望、競爭策略、分部預測（-2030 年）
市場調查報告書
商品編碼
1110905

全球數位藥房市場：按藥物類型、產品類型、平台、商業模式 - 區域展望、競爭策略、分部預測（-2030 年）

Global Digital Pharmacy Market- By Drug Type, By Product, By Platform, By Business Model, By Geographic Coverage- Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 238 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

到 2030 年，全球數位藥房市場規模預計將增長 16.8%，達到 3342.5 億美元。

消費者對在線購買藥品的需求不斷上升、市場整合和合作夥伴關係以及人口老齡化的加劇正在推動數位藥房市場的增長。然而，越來越多的藥店和越來越多的依賴藥劑師提供治療支持的患者正在抑制市場的增長。

本報告研究和分析全球數位藥房市場，提供包括市場動態、市場分析和公司概況在內的系統信息。

內容

第一章介紹

  • 調查範圍
  • 細分市場分析

第二章研究方法

  • 調查數據源
    • 輔助數據
    • 主要數據
    • SPER 內部數據庫
    • KOL 見解
  • 市場規模估計
    • 自上而下和自下而上的方法
  • 數據三角剖分

第 3 章執行摘要

第 4 章市場動態

  • 分析驅動因素、制約因素、機遇和挑戰
    • 驅動程序
    • 約束因素
    • 機會
    • 任務
  • COVID-19 對全球數位藥房市場的影響

第五章市場變量與展望

  • SWOT 分析
    • 實力
    • 弱點
    • 機會
    • 威脅
  • PESTEL 分析
    • 政治局勢
    • 經濟狀況
    • 社會狀況
    • 技術情況
    • 環境狀況
    • 法律狀況
  • 波特五力分析
    • 供應商的議價能力
    • 買家的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的敵對關係
  • 熱圖分析

第 6 章全球數位藥房市場（百萬美元）（2019-2030）：按藥物類型

  • 非處方產品
    • 非處方藥的易用性和便利性推動了市場增長
  • 處方藥
    • 由於人口老齡化和隨之而來的慢性病增加，對處方藥的需求不斷增加

第 7 章全球數位藥房市場（百萬美元）（2019-2030）：按產品分類

  • 藥物和治療
    • 糖尿病護理
    • 心臟護理
    • 腫瘤
  • 維生素和補充劑
    • COVID-19 大流行引發對免疫相關補充劑的需求增加，推動市場增長
  • 個人護理用品
    • 對個人健康和衛生的日益濃厚的興趣推動了市場增長
  • 其他產品

第 8 章全球數位藥房市場（百萬美元）（2019-2030）：按平台分類

  • 應用程序 (AAPS)
    • 由於非接觸式交付等優勢，對 AAPS 的需求不斷上升
  • 網站
    • 網站為促進市場增長而提供的促銷、折扣和優惠

第 9 章全球數位藥房市場（百萬美元）（2019-2030 年）：按商業模式分類

  • 俘虜
    • 專屬模式的靈活性、可訪問性和可負擔性——推動市場增長的關鍵因素
  • 聚合器
    • 與聚合器模式相關的高質量服務推動市場增長
  • 特許經營
    • 藥房特許經營數量的增加推動市場增長

第 10 章全球數位藥房市場（百萬美元）（2019-2030 年）：按地域覆蓋

  • 市區
    • 由於互聯網在城市地區的快速普及，促進該細分市場的增長
  • 農村地區
    • 政府推動農村地區數位藥店需求的舉措

第 11 章全球數位藥房市場（百萬美元）（2019-2030）：按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 中東和非洲
    • 沙特阿拉伯王國
    • 阿拉伯聯合酋長國
    • 其他中東

第 12 章公司簡介

  • Amazon.com Inc.
  • Apex Pharmacy
  • Apollo Pharmacy
  • Cigna
  • Costco Wholesale Corporation
  • CVS Health
  • DocMorris
  • Giant Eagle Inc.
  • GoodRx
  • HealthWarehouse Inc.
  • Hims & Hers Health Inc.
  • Lloyds Pharmacy
  • Netmeds.com
  • NorthWestPharmacy.com
  • Optum Inc.
  • PharmEasy
  • Pharmex Direct Inc.
  • Rexall Pharmacy Group ULC
  • Rite Aid Corp.
  • Ro Pharmacy
  • Rx Outreach
  • Shop-apotheke.com
  • Tata 1mg
  • TELUS
  • The Independent Pharmacy
  • The Kroger Co.
  • Walgreen Co.
  • Walmart Inc.
簡介目錄
Product Code: PHAR2207

According to SPER Market Research, the Digital Pharmacy Market is estimated to reach USD 334.25 billion by 2030 with a CAGR of 16.8%.

The rising consumer desire for purchasing pharmaceuticals online during and after the COVID-19 pandemic, market consolidation and partnerships, and the rising elderly population all contribute to the sector's growth. During the projected period, an increasing number of violent pharmacies and patients who depend on pharmacists for therapeutic support are anticipated to hinder the growth of this market.

Impact of COVID-19 on the Global Digital Pharmacy Market

Other significant reasons boosting the market growth include the expanding number of internet users, more access to online services, and the increased deployment of e-prescriptions in healthcare services in the aftermath of the COVID-19 epidemic. In March 2020, CVS Health began implementing new strategies to balance the demand for medications used throughout the treatment of both COVID-19 and other chronic conditions. In November 2020, Amazon will start an online pharmacy service in the United States for both generic and prescription pharmaceuticals. Before COVID-19, 70% of families were chronic-first consumers of digital pharmacy because they saw superior value in these affordable and convenient services. Nevertheless, as digital pharmacy proved the need of the hour during the lockdown period, an identical amount of chronic-first and acute-first families were onboarded. Furthermore, the rising demand for over-the-counter (OTC) items such as masks, sanitizers, thermometers, and steamers, among others, is supporting the expansion of the digital pharmacy market. As a result, the rapid use of OTC products will benefit the digital pharmacy sector.

Scope of the report:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030
  • Segments covered: By Drug Type, By Product, By Platform, By Business Model, By Geographic Coverage
  • Geographies covered: North America, Europe, Asia Pacific, Latin America, Middle East, Africa
  • Companies Covered: Amazon.com Inc., Apex Pharmacy, Apollo Pharmacy, Cigna, Costco Wholesale Corporation, CVS Health, DocMorris, Giant Eagle Inc., GoodRx, HealthWarehouse Inc., Hims & Hers Health Inc., Lloyds Pharmacy, Netmeds.com, NorthWestPharmacy.com, Optum Inc., PharmEasy, Pharmex Direct Inc., Rexall Pharmacy Group ULC, Rite Aid Corp., Ro Pharmacy, Rx Outreach, Shop-apotheke.com, Tata 1mg, TELUS, The Independent Pharmacy, The Kroger Co., Walgreen Co., Walmart Inc.

Global Digital Pharmacy Market, By Drug Type:

Based on the Drug Type, Global Digital Pharmacy Market is segmented as; Over-The-Counter Products (Ease of use and convenience associated with Over-The-Counter products to drive market growth), Prescription Medicines (Growing geriatric population and subsequent increase in chronic diseases to drive the demand for prescription medication).

Global Digital Pharmacy Market, By Product:

Based on the Product, Global Digital Pharmacy Market is segmented as; Medicines and Treatments {Diabetes Care (Growing global diabetic population will ensure strong demand for diabetes care medicines & treatments), Heart Care (Rising incidence of cardiovascular diseases drives the demand for heart care medicines & treatments), Oncology (Increasing prevalence of cancer is a major factor driving the growth of this market segment, Other medicines & treatments)}, Vitamins and Supplements (Growing demand for immunity-associated supplements in the wake of the COVID-19 pandemic to drive market growth), Personal Care Products (Growing focus on personal health & hygiene to drive market growth), Other Products.

Global Digital Pharmacy Market, By Platform:

Based on the Platform, Global Digital Pharmacy Market is segmented as; Applications (AAPS) (Advantages such as contactless delivery will drive the demand for AAPS), Websites (Promotions, discounts, and offers provided by websites to drive market growth).

Global Digital Pharmacy Market, By Business Model:

Based on the Business Model, Global Digital Pharmacy Market is segmented as; Captive (Flexibility, accessibility, and affordability of captive models-key factors driving market growth), Aggregator (Quality services associated with aggregator models to drive market growth), Franchise (Growing number of pharmacy franchises to drive market growth).

Global Digital Pharmacy Market, By Geographic Coverage:

Based on the Geographic Coverage, Global Digital Pharmacy Market is segmented as; Urban Areas (Rapid internet penetration in urban areas to drive market growth in this segment), Rural Areas (Government initiatives to fuel the demand for digital pharmacies in rural areas).

Global Digital Pharmacy Market, By Region:

North America owns the prime share of this market; the major factors of the market's growth in the region are the increasing incidence of chronic illnesses, the growing amount of medicine prescriptions brought on by the region's rapidly aging population, and the expansion of key market participants in the area.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Global Digital Pharmacy Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Global Digital Pharmacy Market, By Drug Type, 2019-2030 (USD Million)

  • 6.1. Over-The-Counter Products
    • 6.1.1. Ease of use and convenience associated with Over-The-Counter products to drive market growth
  • 6.2. Prescription Medicines
    • 6.2.1. Growing geriatric population and subsequent increase in chronic diseases to drive the demand for prescription medication

7. Global Digital Pharmacy Market, By Product, 2019-2030 (USD Million)

  • 7.1. Medicines and Treatments
    • 7.1.1. Diabetes Care
      • 7.1.1.1 Growing global diabetic population will ensure strong demand for diabetes care medicines & treatments
    • 7.1.2. Heart Care
      • 7.1.2.1 Rising incidence of cardiovascular diseases drives the demand for heart care medicines & treatments
    • 7.1.3. Oncology
      • 7.1.3.1 Increasing prevalence of cancer is a major factor driving the growth of this market segment
      • 7.1.3.2 Other medicines & treatments
  • 7.2. Vitamins and Supplements
    • 7.2.1 Growing demand for immunity-associated supplements in the wake of the Covid-19 pandemic to drive market growth
  • 7.3. Personal Care Products
    • 7.3.1 Growing focus on personal health & hygiene to drive market growth
  • 7.4. Other Products

8. Global Digital Pharmacy Market, By Platform, 2019-2030 (USD Million)

  • 8.1. Applications (AAPS)
    • 8.1.1 Advantages such as contactless delivery will drive the demand for AAPS
  • 8.2. Websites
    • 8.2.1 Promotions, discounts, and offers provided by websites to drive market growth

9. Global Digital Pharmacy Market, By Business Model, 2019-2030 (USD Million)

  • 9.1. Captive
    • 9.1.1 Flexibility, accessibility, and affordability of captive models-key factors driving market growth
  • 9.2. Aggregator
    • 9.2.1 Quality services associated with aggregator models to drive market growth
  • 9.3. Franchise
    • 9.3.1 Growing number of pharmacy franchises to drive market growth

10. Global Digital Pharmacy Market, By Geographic Coverage, 2019-2030 (USD Million)

  • 10.1 Urban Areas
    • 10.1.1 Rapid internet penetration in urban areas to drive market growth in this segment
  • 10.2 Rural Areas
    • 10.2.1 Government initiatives to fuel the demand for digital pharmacies in rural areas

11. Global Digital Pharmacy Market, By Region, 2019-2030 (USD Million)

  • 11.1 North America
    • 11.1.1. United States
    • 11.1.2. Canada
    • 11.1.3. Mexico
  • 11.2 Europe
    • 11.2.1. Germany
    • 11.2.2. United Kingdom
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3 Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Australia
    • 11.3.5. South Korea
    • 11.3.6. Rest of Asia-Pacific
  • 11.4 South America
    • 11.4.1. Brazil
    • 11.4.2. Argentina
    • 11.4.3. Rest of South America
  • 11.5 Middle East & Africa
    • 11.5.1. Kingdom of Saudi Arabia
    • 11.5.2. United Arab Emirates
    • 11.5.3. Rest of Middle East & Africa

12. Company Profiles

  • 12.1 Amazon.com Inc.
    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary
    • 12.1.4. Recent developments
  • 12.2 Apex Pharmacy
    • 12.2.1. Company details
    • 12.2.2. Financial outlook
    • 12.2.3. Product summary
    • 12.2.4. Recent developments
  • 12.3 Apollo Pharmacy
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary
    • 12.3.4. Recent developments
  • 12.4 Cigna
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary
    • 12.4.4. Recent developments
  • 12.5 Costco Wholesale Corporation
    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary
    • 12.5.4. Recent developments
  • 12.6 CVS Health
    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary
    • 12.6.4. Recent developments
  • 12.7 DocMorris
    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary
    • 12.7.4. Recent developments
  • 12.8 Giant Eagle Inc.
    • 12.8.1. Company details
    • 12.8.2. Financial outlook
    • 12.8.3. Product summary
    • 12.8.4. Recent developments
  • 12.9 GoodRx
    • 12.9.1. Company details
    • 12.9.2. Financial outlook
    • 12.9.3. Product summary
    • 12.9.4. Recent developments
  • 12.10 HealthWarehouse Inc.
    • 12.10.1. Company details
    • 12.10.2. Financial outlook
    • 12.10.3. Product summary
    • 12.10.4. Recent developments
  • 12.11 Hims & Hers Health Inc.
    • 12.11.1. Company details
    • 12.11.2. Financial outlook
    • 12.11.3. Product summary
    • 12.11.4. Recent developments
  • 12.12 Lloyds Pharmacy
    • 12.12.1. Company details
    • 12.12.2. Financial outlook
    • 12.12.3. Product summary
    • 12.12.4. Recent developments
  • 12.13 Netmeds.com
    • 12.13.1. Company details
    • 12.13.2. Financial outlook
    • 12.13.3. Product summary
    • 12.13.4. Recent developments
  • 12.14 NorthWestPharmacy.com
    • 12.14.1. Company details
    • 12.14.2. Financial outlook
    • 12.14.3. Product summary
    • 12.14.4. Recent developments
  • 12.15 Optum Inc.
    • 12.15.1. Company details
    • 12.15.2. Financial outlook
    • 12.15.3. Product summary
    • 12.15.4. Recent developments
  • 12.16 PharmEasy
    • 12.16.1. Company details
    • 12.16.2. Financial outlook
    • 12.16.3. Product summary
    • 12.16.4. Recent developments
  • 12.17 Pharmex Direct Inc.
    • 12.17.1. Company details
    • 12.17.2. Financial outlook
    • 12.17.3. Product summary
    • 12.17.4. Recent developments
  • 12.18 Rexall Pharmacy Group ULC
    • 12.18.1. Company details
    • 12.18.2. Financial outlook
    • 12.18.3. Product summary
    • 12.18.4. Recent developments
  • 12.19 Rite Aid Corp.
    • 12.19.1. Company details
    • 12.19.2. Financial outlook
    • 12.19.3. Product summary
    • 12.19.4. Recent developments
  • 12.20 Ro Pharmacy
    • 12.20.1. Company details
    • 12.20.2. Financial outlook
    • 12.20.3. Product summary
    • 12.20.4. Recent developments
  • 12.21 Rx Outreach
    • 12.21.1. Company details
    • 12.21.2. Financial outlook
    • 12.21.3. Product summary
    • 12.21.4. Recent developments
  • 12.22 Shop-apotheke.com
    • 12.22.1. Company details
    • 12.22.2. Financial outlook
    • 12.22.3. Product summary
    • 12.22.4. Recent developments
  • 12.23 Tata 1mg
    • 12.23.1. Company details
    • 12.23.2. Financial outlook
    • 12.23.3. Product summary
    • 12.23.4. Recent developments
  • 12.24 TELUS
    • 12.24.1. Company details
    • 12.24.2. Financial outlook
    • 12.24.3. Product summary
    • 12.24.4. Recent developments
  • 12.25 The Independent Pharmacy
    • 12.25.1. Company details
    • 12.25.2. Financial outlook
    • 12.25.3. Product summary
    • 12.25.4. Recent developments
  • 12.26 The Kroger Co.
    • 12.26.1. Company details
    • 12.26.2. Financial outlook
    • 12.26.3. Product summary
    • 12.26.4. Recent developments
  • 12.27 Walgreen Co.
    • 12.27.1. Company details
    • 12.27.2. Financial outlook
    • 12.27.3. Product summary
    • 12.27.4. Recent developments
  • 12.28 Walmart Inc.
    • 12.28.1. Company details
    • 12.28.2. Financial outlook
    • 12.28.3. Product summary
    • 12.28.4. Recent developments